Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host hepatocyte surface attachment factors represent a heterogeneous group of molecules on the liver cell membrane that pathogens utilize for docking and entry. These factors include proteins like the sodium taurocholate cotransporting polypeptide (NTCP), scavenger receptor class B type I (SR-BI), and CD81, as well as heparan sulfate proteoglycans (HSPGs) (Yan et al., 2012, eLife; Zeisel et al., 2013, Journal of Hepatology). Their primary physiological functions often involve the transport of bile acids, lipids, or signaling molecules, which are hijacked by viruses such as HBV, HCV, and HDV, or parasites like Plasmodium (Silvie et al., 2003, Nature Medicine). In the context of Hepatitis B and D, NTCP is the definitive receptor, and its inhibition prevents the virus from infecting new hepatocytes. For Hepatitis C, a multi-step entry process involves initial attachment to HSPGs followed by interaction with SR-BI, CD81, and tight junction proteins (Barth et al., 2003, JBC). Therapeutic agents targeting these factors, such as the entry inhibitor bulevirtide, provide a mechanism to interrupt the viral life cycle at the earliest stage. However, because these factors perform essential host functions, drug development must balance antiviral efficacy with the risk of metabolic disruption, such as altered bile acid homeostasis. Monitoring biomarkers like serum bile acids or viral load is crucial for assessing the safety and efficacy of such interventions.
Inhibition of pathogen attachment and entry into host hepatocytes by blocking specific surface receptors or attachment factors.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host hepatocyte surface attachment factors.